BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,304,588 | -37.9% | 1,275,000 | -39.3% | 0.00% | 0.0% |
| Q3 2022 | $2,101,000 | +112.4% | 2,100,000 | +110.0% | 0.00% | – |
| Q2 2022 | $989,000 | +92.4% | 1,000,000 | +100.0% | 0.00% | – |
| Q3 2021 | $514,000 | -77.2% | 500,000 | -77.2% | 0.00% | -100.0% |
| Q1 2021 | $2,257,000 | +1120.0% | 2,193,000 | +1153.1% | 0.00% | – |
| Q3 2018 | $185,000 | -63.4% | 175,000 | -65.0% | 0.00% | -100.0% |
| Q2 2018 | $506,000 | -88.8% | 500,000 | -88.9% | 0.00% | -93.3% |
| Q3 2017 | $4,517,000 | – | 4,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |